Literature DB >> 17060457

Dormant Wnt-initiated mammary cancer can participate in reconstituting functional mammary glands.

Shelley A Gestl1, Travis L Leonard, Jessica L Biddle, Michael T Debies, Edward J Gunther.   

Abstract

The minimal residual disease foci that beget breast cancer relapse after a period of disease dormancy remain uncharacterized despite their enormous clinical importance. To model dormant breast cancer in vivo, we employed a transgenic mouse model in which Wnt1-initiated mammary cancer is doxycycline dependent. After regression of Wnt-dependent cancers, subclinical disease lesions were propagated in vivo using classical tissue recombination techniques. Surprisingly, outgrowths derived from dormant malignant tissue reconstituted morphologically normal ductal trees in wild-type mammary fat pads. Whereas hyperplasia-derived outgrowths remained benign, outgrowths derived from dormant malignancy underwent a morphological transition suggesting single-step transformation following reactivation of Wnt signaling and rapidly yielded invasive mammary tumors. Remarkably, outgrowths derived from dormant malignancy could be serially propagated in vivo and retained the potential to undergo lobuloalveolar differentiation in response to hormones of pregnancy. Matching somatic H-Ras mutations shared by antecedent tumors and descendant mammary ductal outgrowths confirmed their clonal relatedness. Thus, propagation of epithelium that possesses a latent malignant growth program reveals impressive regenerative and developmental potential, supporting the notion that dormant mammary cancers harbor transformed mammary progenitor cells. Our results define an experimental paradigm for elucidating biological properties of dormant malignancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17060457      PMCID: PMC1800647          DOI: 10.1128/MCB.01525-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  42 in total

Review 1.  Applying the principles of stem-cell biology to cancer.

Authors:  Ricardo Pardal; Michael F Clarke; Sean J Morrison
Journal:  Nat Rev Cancer       Date:  2003-12       Impact factor: 60.716

Review 2.  Socializing with the neighbors: stem cells and their niche.

Authors:  Elaine Fuchs; Tudorita Tumbar; Geraldine Guasch
Journal:  Cell       Date:  2004-03-19       Impact factor: 41.582

3.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

4.  Essential role for oncogenic Ras in tumour maintenance.

Authors:  L Chin; A Tam; J Pomerantz; M Wong; J Holash; N Bardeesy; Q Shen; R O'Hagan; J Pantginis; H Zhou; J W Horner; C Cordon-Cardo; G D Yancopoulos; R A DePinho
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

5.  Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells.

Authors:  Yi Li; Bryan Welm; Katrina Podsypanina; Shixia Huang; Mario Chamorro; Xiaomei Zhang; Tracey Rowlands; Mikala Egeblad; Pam Cowin; Zena Werb; Lee K Tan; Jeffrey M Rosen; Harold E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

6.  Gene expression phenotypic models that predict the activity of oncogenic pathways.

Authors:  Erich Huang; Seiichi Ishida; Jennifer Pittman; Holly Dressman; Andrea Bild; Mark Kloos; Mark D'Amico; Richard G Pestell; Mike West; Joseph R Nevins
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

7.  Reprogramming of a melanoma genome by nuclear transplantation.

Authors:  Konrad Hochedlinger; Robert Blelloch; Cameron Brennan; Yasuhiro Yamada; Minjung Kim; Lynda Chin; Rudolf Jaenisch
Journal:  Genes Dev       Date:  2004-08-01       Impact factor: 11.361

8.  Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.

Authors:  Andrea Rosner; Keiko Miyoshi; Esther Landesman-Bollag; Xin Xu; David C Seldin; Amy R Moser; Carol L MacLeod; G Shyamala; Amy E Gillgrass; Robert D Cardiff
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

9.  The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells.

Authors:  Bob Y Liu; Sean P McDermott; Shariq S Khwaja; Caroline M Alexander
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-12       Impact factor: 11.205

Review 10.  Stem cells in normal breast development and breast cancer.

Authors:  Gabriela Dontu; Muhammad Al-Hajj; Wissam M Abdallah; Michael F Clarke; Max S Wicha
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

View more
  6 in total

Review 1.  The glandular stem/progenitor cell niche in airway development and repair.

Authors:  Xiaoming Liu; John F Engelhardt
Journal:  Proc Am Thorac Soc       Date:  2008-08-15

2.  A BAC transgenic reporter recapitulates in vivo regulation of human telomerase reverse transcriptase in development and tumorigenesis.

Authors:  Wenwen Jia; Shuwen Wang; James W Horner; Ning Wang; Huayan Wang; Edward J Gunther; Ronald A DePinho; Jiyue Zhu
Journal:  FASEB J       Date:  2010-12-06       Impact factor: 5.191

3.  Wnt/β-catenin Pathway Modulates the Sensitivity of the Mutant FLT3 Receptor Kinase Inhibitors in a GSK-3β Dependent Manner.

Authors:  Jingrui Jiang; James D Griffin
Journal:  Genes Cancer       Date:  2010-02

Review 4.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

Review 5.  Wnt signaling, stem cells, and the cellular origin of breast cancer.

Authors:  Charlotta Lindvall; Wen Bu; Bart O Williams; Yi Li
Journal:  Stem Cell Rev       Date:  2007-06       Impact factor: 6.692

6.  Combining functional genomics strategies identifies modular heterogeneity of breast cancer intrinsic subtypes.

Authors:  Nima Pouladi; Richard Cowper-Sallari; Jason H Moore
Journal:  BioData Min       Date:  2014-12-29       Impact factor: 2.522

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.